Klinische studies weke delen sarcomen

Op deze pagina

Planned

RINGSIDE - AL-DES-Ol

A Phase 2/3, Randomized, Multicenter Study ro Evaluate AL102 in Patients with Progressing Desmoid Tumors

Ongoing

RAIN-3201

A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients
with Dedifferentiated Liposarcoma

Closed

I5B-MC-JGDQ

An Open-Label, Multicenter, Phase 1a/1b Study of Olaratumab (LY3012207) Plus Pembrolizumab (MK3475) in Patients With Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma (STS) Who Have Failed Standard Treatments

ANITA EORTC 1506

A Phase II Multicenter Study Comparing the Efficacy of the Oral Angiogenesis Inhibitor Nintedanib With the Intravenous Cytotoxic Compound Ifosfamide for Treatment of Patients With Advanced Metastatic Soft Tissue Sarcoma After Failure of Systemic Non-oxazaphosporine-based First Line Chemotherapy for Inoperable Disease

ANNOUNCE I5B-MC-JGDJ

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus
Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma

DeFi NIR301DT

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients with Progressing Desmoid Tumors (DTs)/ Aggressive Fibromatosis (AF)

EPIZYME EZH-202

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma

TRUST EZH-501

Tazemetostat Rollover Study : An Open-Label Rollover Study

Laatste aanpassing: 10 september 2021